药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Orciprenaline
Tetrazepam
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Tetrazepam.
Orciprenaline
Trichloroethylene
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Trichloroethylene.
Orciprenaline
Febarbamate
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Febarbamate.
Orciprenaline
Sultopride
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Sultopride.
Orciprenaline
Clothiapine
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Clothiapine.
Orciprenaline
Proxibarbal
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Proxibarbal.
Orciprenaline
Quinupramine
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Quinupramine.
Orciprenaline
Propanidid
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Propanidid.
Orciprenaline
Dibenzepin
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Dibenzepin.
Orciprenaline
Apronalide
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Apronalide.
Orciprenaline
Medifoxamine
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Medifoxamine.
Orciprenaline
Butaperazine
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Butaperazine.
Orciprenaline
Amitriptylinoxide
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Amitriptylinoxide.
Orciprenaline
Valnoctamide
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Valnoctamide.
Orciprenaline
Nefiracetam
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Nefiracetam.
Orciprenaline
Tiapride
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Tiapride.
Orciprenaline
Hypericin
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Hypericin.
Orciprenaline
Neosaxitoxin
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Neosaxitoxin.
Orciprenaline
Prothipendyl
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Prothipendyl.
Orciprenaline
Pivagabine
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Pivagabine.